Orion Infusion Limited (DSE:ORIONINFU)

Dada Nexus Revenue

Orion Infusion had revenue of 101.49M BDT in the quarter ending March 31, 2025, a decrease of -51.42%. This brings the company's revenue in the last twelve months to 675.08M, down -20.62% year-over-year. In the fiscal year ending June 30, 2024, Orion Infusion had annual revenue of 827.42M with 2.13% growth.

• Revenue (ttm): 675.08M
• Revenue Growth: -20.62%
• P/S Ratio: 11.93
• Revenue / Employee: 940.23K
• Employees: 718
• Market Cap: 8.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	827.42M	17.26M	2.13%
Jun 30, 2023	810.15M	-19.42M	-2.34%
Jun 30, 2022	829.57M	102.17M	14.05%
Jun 30, 2021	727.40M	-13.47M	-1.82%
Jun 30, 2020	740.87M	-69.43M	-8.57%